Carmignac Gestion’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$100M Buy
4,311,997
+2,418,971
+128% +$75.4M 1.54% 18
2025
Q4
$83.8M Buy
1,893,026
+1,477,798
+356% +$83M 1.13% 23
2025
Q3
$30.4M Hold
415,228
0.45% 41
2025
Q2
$25.5M Buy
415,228
+45,228
+12% +$2.52M 0.39% 42
2025
Q1
$21.5M Buy
370,000
+52,700
+17% +$3.33M 0.35% 42
2024
Q4
$16.9M Buy
317,300
+73,000
+30% +$3.57M 0.27% 51
2024
Q3
$10.6M Buy
244,300
+31,300
+15% +$1.04M 0.18% 61
2024
Q2
$5.96M Buy
+213,000
New +$5.62M 0.1% 72

Other funds holding DOCS

Carmignac Gestion's DOCS Position: Q1 2026 in Review

Carmignac Gestion increased its Doximity (DOCS) stake by 128% in Q1 2026, buying an estimated $75.4M and bringing the position to 4,311,997 shares worth $100M. The position accounts for 1.54% of the portfolio, ranked #18.

Carmignac Gestion first reported a position in DOCS in Q2 2024 and has held it in 8 quarters since. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Carmignac Gestion held 4,311,997 shares of Doximity worth $100M as of Q1 2026.
  • Carmignac Gestion bought 2,418,971 Doximity shares in Q1 2026, an estimated $75.4M.
  • Doximity made up 1.54% of Carmignac Gestion's portfolio in Q1 2026, its #18 holding.
  • Carmignac Gestion first reported a position in Doximity in Q2 2024 and has held it in 8 quarters since.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Carmignac Gestion's 13F filing for Q1 2026, filed 15 Jun 2026.